Login to Your Account

ImClone, Bristol-Myers Plan BLA, Try Again For Erbitux Approval

By Kim Coghill

Monday, June 9, 2003
While ImClone Inc.'s former CEO Samuel Waksal waits to be sentenced on a series of fraud and other charges this week, the company he co-founded is pulling together a regulatory application on the long-awaited colorectal cancer drug Erbitux. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription